Diagnostic Value of C-Reactive Protein for Predicting Activity Level of Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 7, 2006, Pages 882-887

  Chamouard, Patrick ^a   Richert, Zoe ^a   Meyer, Nicolas ^b   Rahmi, Gabriel ^a   Baumann, René ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PROBABILITY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROHN DISEASE; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 33745634371     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.02.003     Document Type: Article

References (29)

1. Best W.R., Becktel J.M., Singleton J.W., et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70 (1976) 439-444
2. Harvey R.F., and Bradshaw J.M. A simple index of Crohn's disease activity. Lancet 1 (1980) 514
3. Van Hees P.A., van Elteren P.H., van Lier H.J., et al. An index of inflammatory activity in patients with Crohn's disease. Gut 21 (1980) 279-286
4. Sostegni R., Daperno M., Scaglione N., et al. Crohn's disease. monitoring disease activity. Aliment Pharmacol Ther 17 (2003) 11-17
5. Sandborn W.J., Colombel J.F., Enns R., et al. Efficacy assessment of natalizumab in patients with Crohn's disease and prior history of anti-TNF therapy. results from ENACT-1. Gastroenterology 126 Suppl 2 (2004) A76
6. Tillet W.S., and Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of the Pneumococcus. J Exp Med 52 (1930) 561-571
7. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
8. Tall A.R. C-reactive protein reassessed. N Engl J Med 350 (2004) 1450-1452
9. Vermeire S., van Assche G., and Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10 (2004) 661-665
10. Fagan E.A., Dyck R.F., Maton P.N., et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 12 (1982) 351-359
11. Lennard-Jones J.E. Definition and diagnosis. In: Lennard-Jones J.E. (Ed). Skandia International Symposia. regional enteritis (Crohn's disease) (1971), Nordiska Bokhandlen's Förlag, Stockholm 105-112
12. Gasche C., Scholmerich J., Brynskov J., et al. A single classification of Crohn's disease. report of the working party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
13. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 148 (1983) 839-843
14. Conover W.J. Nonparametric statistics. 2nd ed (1980), Wiley & Sons, New York
15. Solem C.A., Loftus E.V., Tremaine W.J., et al. Correlation of C-reactive protein (CRP) with clinical, radiographic and endoscopic activity in inflammatory bowel disease (IBD). Gastroenterology 126 Suppl 2 (2004) A477
16. Poullis A.P., Zar S., Sundaram K.K., et al. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol 14 (2002) 409-412
17. Shine B., Berhouse L., Jones J.E., et al. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta 148 (1985) 105-109
18. Beattie R.M., Walker-Smith J.A., and Murch S.H. Indications for investigation of chronic symptoms. Arch Dis Child 73 (1995) 354-355
19. Boirivant M., Leoni M., Tariciotti D., et al. The clinical significance of serum C reactive protein levels in Crohn's disease. results of a prospective longitudinal study. J Clin Gastroenterol 10 (1988) 401-405
20. Consigny Y., Modigliani R., Colombel J.F., et al. Biological markers of short term relapse in Crohn's disease (CD). Gastroenterology 120 Suppl 1 (2001) A141
21. Travis S.P., Farrant J.M., Ricketts C., et al. Predicting outcome in severe ulcerative colitis. Gut 38 (1996) 905-910
22. Schultz D.R., and Arnold P.I. Properties of acute phase proteins. C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 20 (1990) 129-147
23. Gewurz H., Mold C., Siegel J., et al. C-reactive protein and the acute phase response. Adv Intern Med 27 (1982) 345-372
24. Cambeau E. C-reactive protein. general review and role in the study of infection. Pathol Biol (Paris) 36 (1998) 1232-1236
25. Louis E., Vermeire S., Rutgeerts P., et al. A positive response to infliximab in Crohn's disease. association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. Scand J Gastroenterol 37 (2002) 818-824
26. Whitehead A.S., Bruns G.A., Markham A.F., et al. Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science 221 (1983) 69-71
27. Russell A.I., Cunninghame Graham D.S., Sheperd C., et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13 (2004) 137-147
28. Schreiber S., Rutgeerts P., Fedorak R.N., et al. A randomized placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology 129 (2005) 807-818
29. Lewis J.D. C-reactive protein. anti-placebo or predictor of response. Gastroenterology 129 (2005) 1114-1116